Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MULTIPLE SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02326935
What this trial is testing

Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
American CryoStem Corporation 2
Testing effectiveness (Phase 2)WithdrawnNCT01714089
What this trial is testing

Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Revalesio Corporation
Testing effectiveness (Phase 2)Ended earlyNCT03183869
What this trial is testing

Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients

Who this might be right for
Autoimmune DiseasesRelapsing Multiple Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 14
Early research (Phase 1)Ended earlyNCT02423083
What this trial is testing

Oral Guanabenz for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 2
Testing effectiveness (Phase 2)Study completedNCT01854359
What this trial is testing

Idebenone for Primary Progressive Multiple Sclerosis

Who this might be right for
Multiple SclerosisPrimary Progressive Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 61
Not applicableStudy completedNCT04847596
What this trial is testing

Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 25
Not applicableWithdrawnNCT05482542
What this trial is testing

Optimal Conditioning Regimen for Autologous Transplantation of Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Scripps Health
Not applicableEnded earlyNCT03250169
What this trial is testing

Neurofilaments for NEDA Assessing in MS

Who this might be right for
Multiple Sclerosis
Queen Mary University of London 21
Not applicableStudy completedNCT03872583
What this trial is testing

Understanding Magnetic Resonance Imaging in Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingClinically Isolated Syndrome
Universitätsklinikum Hamburg-Eppendorf 120
Early research (Phase 1)Looking for participantsNCT07369505
What this trial is testing

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Who this might be right for
Breast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more
SAPU NANO (US) LLC 27
Not applicableLooking for participantsNCT04114994
What this trial is testing

Longitudinal Cognitive Assessment by BoCA

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentVascular Dementia+4 more
Alzheimer's Light LLC 10,000
Not applicableLooking for participantsNCT07083856
What this trial is testing

Effects of Reiki and Self-Acupressure Applications

Who this might be right for
Multiple Sclerosis
Firat University 50
Not applicableStudy completedNCT04240379
What this trial is testing

Metacognition Assessment in Patient With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University Hospital, Grenoble 80
Not applicableNot Yet RecruitingNCT07430462
What this trial is testing

Home-Based Exergame Rehabilitation for Upper Limb Function in People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Marina Castel Sánchez 40
Testing effectiveness (Phase 2)Ended earlyNCT05049161
What this trial is testing

A Long-term Extension of Study GNC-401

Who this might be right for
Multiple Sclerosis
GeNeuro Innovation SAS 33
Large-scale testing (Phase 3)Ended earlyNCT04140305
What this trial is testing

Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)

Who this might be right for
Multiple Sclerosis
Celgene 188
Post-approval studies (Phase 4)Looking for participantsNCT06733922
What this trial is testing

ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Novartis Pharmaceuticals 224
Early research (Phase 1)UnknownNCT03113162
What this trial is testing

Reduced-intensity Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Makati Medical Center 15
Not applicableStudy completedNCT06403631
What this trial is testing

Supporting Mental Health in Daily Life After the Diagnosis of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Marta Bassi 361
Not applicableStudy completedNCT02082002
What this trial is testing

Multidimensional Assessment of Fatigue in Multiple Sclerosis- Observational Study - Ticino

Who this might be right for
Multiple Sclerosis
Claudio Gobbi 93
Next Page